Inside the research

Addus HomeCare Corporation

ADUS Research profile · latest available data

Price overview

$113.19

▼ -0.86 (-0.8%)

52w hi$122.75
52w lo$88.49
Vol216.50K
As of25 Sep 2026

The Verdict

Buy

Our score +0.59

Short+0.47
Medium+0.72
Long+0.57

computed 2026-09-27

Key fundamentals

Addus HomeCare Corporation

Healthcare · Medical Care Facilities

Market cap$2.11B
Enterprise value$2.08B
Trailing P/E19.86x
Forward P/E15.07x
EV / EBITDA12.96x
P / S (ttm)1.43x
Profit margin7.1%
Return on equity9.7%
Revenue growth+8.0%
Earnings growth+24.2%
Debt / equity9.48

Layer Breakdown

LayerRawContribution
Fundamental+0.30
Sector+0.08
Technical+0.40
Earnings+0.00
Sentiment-0.01

macro × 1.00 · 2026-09-27

Business overview

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

United States · www.addus.com

Risk Metrics

Beta vs SPX0.39
Corr SPX0.21
Annual vol29.8%
Annual ret-2.6%
Sharpe-0.09
Max DD-34.9%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$133.46
High / Low$155.00 / $102.00
Median$135.00
Analysts13
Strong Buy3
Buy9
Hold1
Sell0
Strong Sell1

Recent rating actions

2026-05-06Citizens→ Market Outperform
2026-03-25Barclays→ Underweight
2026-02-25Stephens & Co.→ Overweight
2026-02-24Barclays→ Underweight
2025-11-13BMO Capital→ Market Perform
2025-11-07RBC Capital→ Outperform

Material Events

DateEvent8-K
2026-08-13Officer / Director Change, Reg FD Disclosure…read
2026-08-03Earnings Release, Reg FD Disclosure…read
2026-06-10Shareholder Voteread
2026-05-04Earnings Release, Reg FD Disclosure…read
2026-02-23Earnings Release, Reg FD Disclosure…read
2025-11-03Earnings Release, Reg FD Disclosure…read
2025-08-07Officer / Director Change, Reg FD Disclosure…read
2025-08-04Earnings Release, Reg FD Disclosure…read
2025-06-23Shareholder Voteread
2025-05-05Earnings Release, Reg FD Disclosure…read
2025-03-11Officer / Director Change, Reg FD Disclosure…read
2025-02-24Earnings Release, Reg FD Disclosure…read

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share99.6%
HHI4,119 (concentrated)

Top Holders

HolderValueShares
State Street Corp$78.13M777.83K
Fidelity / FMR LLC$31.87M317.23K
Citadel Advisors$14.91M148.36K
Capital Research / Capital World$6.42M63.88K
AQR Capital Management$2.04M20.28K
Renaissance Technologies$562.63K5.60K
T. Rowe Price Group$2.52K25.05K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-138-Kview
2026-08-0410-Qview
2026-08-038-Kview
2026-06-234view
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-108-Kview
2026-05-224view
2026-05-214view
2026-05-0510-Qview

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$1.42B+44.2%
Gross profit$339.88M+10.7%
Operating income$90.96M+29.3%
Net income$95.91M+21.9%
Cash from ops$112.25M+23.8%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$114.38$114.65$112.21$113.19216.50K
Sep 24$115.84$115.93$113.57$114.05156.50K
Sep 23$114.30$115.78$113.35$114.93209.20K
Sep 22$116.14$117.17$113.98$114.24154.50K
Sep 21$117.42$118.05$114.74$115.36158.30K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →